Aristote Matondo

Aristote Matondo

Auto-generated profile, based on publicly available information

Aristote Matondo

Department of Chemistry, Faculty of Sciences and Technology, University of Kinshasa, & Research Centre for Pharmacopoeia and Traditional Medicine (CRPMT), Higher Institute of Medical Techniques of Kinshasa, Kinshasa, Democratic Republic of the Congo

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
AMAristote Matondo
Aristote Matondo
Renjith ThomasRenjith Thomas
Renjith Thomas
PTPhilippe Vuka Tsalu
Philippe Vuka Tsalu
CMChristian Tshikala Mukeba
Christian Tshikala Mukeba
VMVirima Mudogo
Virima Mudogo

15 August 2022 in Advances and Applications in Bioinformatics and Chemistry
Verified
Journal Article
Open access
PDF file
AMAristote Matondo
Aristote Matondo
WDWashington Dendera
Washington Dendera
BIBienfait Kabuyaya Isamura
Bienfait Kabuyaya Isamura
KNKoto-Te-Nyiwa Ngbolua
Koto-Te-Nyiwa Ngbolua
HMHilaire Vs Mambo
Hilaire Vs Mambo
VMVirima Mudogo
Virima Mudogo
Background: Since the last COVID-19 outbreak, several approaches have been given a try to quickly tackle this global calamity. One of the well-established strategies is the drug repurposing, which consists in finding new therapeutic uses for approved drugs. Following the same paradigm, we report in the present study, an investigation of the potential inhibitory activity of 5-FU and nineteen of its analogues against the SARS-CoV-2 main protease (3CLpro). Material and Methods: Molecular docking calculations were performed to investigate the binding affinity of the ligands within the active site of 3CLpro. The best binding candidates were further considered for molecular dynamics simulations for 100 ns to gain a time-resolved understanding of the behavior of the guest-host complexes. Furthermore, the profile of druggability of the best binding ligands was assessed based on ADMET predictions. Finally, their chemical reactivity was elucidated using different reactivity descriptors, namely the molecular electrostatic potential (MEP), Fukui functions and frontier molecular orbitals. Results and Discussion: From the calculations performed, four candidates (compounds 14, 15, 16 and 18) show promising results with respect to the binding affinity to the target protease, 3CLpro, the therapeutic profile of druggability and safety. These compounds are maintained inside the active site of 3CLpro thanks to a variety of noncovalent interactions, especially hydrogen bonds, involving important amino acids such as GLU166, HIS163, GLY143, ASN142, HIS172, CYS145. Molecular dynamics simulations suggest that the four ligands are well trapped within the active site of the protein over a time gap of 100 ns, ligand 18 being the most retained. Conclusion: In line with the findings reported herein, we recommend that further in-vitro and in-vivo investigations are carried out to shed light on the possible mechanism of pharmacological action of the proposed ligands.

1 November 2018 in Chemical Physics Letters
Verified
Journal Article
Closed access
AMAristote Matondo
Aristote Matondo
CMChristian Tshikala Mukeba
Christian Tshikala Mukeba
MMMayaliwa Muzomwe
Mayaliwa Muzomwe
BNBeaudrique Mboko Nsimba
Beaudrique Mboko Nsimba
PTPhilippe Vuka Tsalu
Philippe Vuka Tsalu

24 December 2023 in Results in Chemistry
Verified
Journal Article
Open access
JMJean-Gonfi Mvondo Mbala
Jean-Gonfi Mvondo Mbala
DMDani Thierry Mawete
Dani Thierry Mawete
AMAlain Nanikafuako Makiese
Alain Nanikafuako Makiese
PKProsper Lwanzo Kwiraviwe
Prosper Lwanzo Kwiraviwe
BPBibiche Kuyubuka Pangu
Bibiche Kuyubuka Pangu
SBSylvie-Mireille Bambi-Nyanguile
Sylvie-Mireille Bambi-Nyanguile

16 January 2022 in Natural Resources for Human Health
Verified
Journal Article
Open access
CAColette Masengo Ashande
Colette Masengo Ashande
AMAdrien Tuwisana Masunda
Adrien Tuwisana Masunda
JNJean-Paul Koto-Te Nyiwa Ngbolua
Jean-Paul Koto-Te Nyiwa Ngbolua
JKJason Thambwe Kilembe
Jason Thambwe Kilembe
AMAristote Matondo
Aristote Matondo
VMVirima Mudogo
Virima Mudogo
Diabetes mellitus is a major public health problem in the world. In Africa, more than 80% of patients use plants for their treatment. However, the methods of validation of endogenous knowledge usually used are costly. The alternative method developed in this study aims at creating hyperglycemia in vitro and exploiting the metabolic pathway involving glucose oxidase for UV-visible spectrophotometric screening of medicinal plants’ antidiabetic activity. The evolution of glucose oxidation as a function of drug concentration is followed by UV-visible spectrophotometry. The formation of the stable complex between the enzyme and the inhibitor is studied using molecular docking. Drugs used (Gliben) and plant extracts exhibited an in vitro hypoglycemic effect by reducing exponentially, in vitro, the level of free glucose. The results also showed that L. multiflora is more active than V. amygdalina (IC50: 1.36 ± 0.09 mg/mL Vs IC50: 3.00 ± 0.54 mg/mL). Gliben (0.5 mg/mL) and L. multiflora (2 mg/mL) reduced both the rate of oxidation of glucose by glucose oxidase (catalytic power Vmax: 0.84 ± 0.11 mg*mL-1*min-1 for Gliben and 1.72 ± 0.13 mg*mL-1*min-1 for L. multiflora); and the affinity of this enzyme for its substrate-glucose (KM: 15.11 ± 2.72 mg*mL-1 for Gliben and 9.17 ± 1.56 mg*mL-1 for L. multiflora) when these results are compared to enzyme catalysis in the absence of inhibitor (Vmax: 2.86 ± 0.44 mg*mL-1*min-1; KM: 8.07 ± 1.96 mg*mL-1). The binding of GOX (1GAL) to selected phytocompounds derived from L. multiflora was confirmed by molecular docking. The most stable complexes were obtained for four compounds; 8 (-10.1±0.0 Kcal/mol), 6 (-9.5±0.1 Kcal/mol), 3 (-8.3±0.0 Kcal/mol) and 9 (-8.2±0.1 Kcal/mol). Among these, compounds 8 and 6 formed complexes with the enzyme stabilized by hydrogen bonds, the compound 8 forms 5 hydrogen bonds (ASN514, ASP424, ARG95, TYP68, LEU65) while compound 6 forms 2 hydrogen bonds (ASN514 and SER422). However, no H-bonding interaction occurs in the complex that involves ligands 9 and 3 despite their high binding energy (-8.2±0.1 Kcal/mol and -8.3±0.0 Kcal/mol respectively). Glucose oxidase can serve as a marker enzyme for in vitro antidiabetic activity evaluation of medicinal plants.

1 January 2023 in South African Journal of Chemistry
Verified
Journal Article
Open access
PDF file
BIBienfait Kabuyaya Isamura
Bienfait Kabuyaya Isamura
IPIssofa Patouossa
Issofa Patouossa
IKIsaac Kaba
Isaac Kaba
AMAristote Matondo
Aristote Matondo
PMPius Tshimankinda MPIANA
Pius Tshimankinda MPIANA
In this study, we report a computational investigation of the antioxidant activity of five plant food benzoic acid derivatives, namely gallic acid (GA), para-hydroxybenzoic acid (PHBA), protocatechuic acid (PCA), syringic acid (SA), and vanillic acid (VA). Based on a series of computed thermodynamics parameters, we have developed a comparative debate regarding their free radical scavenging activity in the gas phase and polar solutions (considering water and methanol solvents). This discussion expands to the elucidation of both the most preferred mechanism and the order of antioxidant activity in each environment. Paradoxically, calculations using the harmonic oscillator model of aromaticity (HOMA) suggest that H abstraction radicals gain stability as the central benzene ring loses structural aromaticity. Finally, spin densities and Fukui function f0 appear to be good indicators of the local reactivity of the five antioxidants toward free radicals.